INOGEN INC (INGN)
Health Care · respiratory medical devices · NASDAQ
Inogen is a respiratory health technology company providing portable and stationary oxygen concentrators designed to improve mobility and quality of life for patients with chronic respiratory conditions.
What INOGEN INC does
Inogen is a medical technology company that develops, manufactures, and markets respiratory health products primarily for the homecare setting. Its core offerings include portable and stationary oxygen concentrators for chronic respiratory conditions like COPD, as well as airway clearance devices and CPAP masks. The company distributes its products globally, including through a strategic collaboration with Yuwell to enhance its presence in the Chinese market.
Recent developments
In Q2 2026, the company raised its full-year 2026 adjusted EBITDA guidance to approximately $4.0 million and updated its revenue guidance to $355–$361 million. The company recently launched the Rove 6 portable oxygen concentrator in Canada and appointed Andy Reding as Chief Operating Officer.
From INOGEN INC's filing of 2026-08-07.
Themes: respiratory care, oxygen therapy, chronic obstructive pulmonary disease (COPD), homecare technology, airway clearance, sleep apnea therapy
Fundamentals
- Price$5.94 as of 2026-10-08 close
- Market cap$158M as of 2026-08-01 (share count; price 2026-10-08)
- 1-year return-31.6% 2025-10-08 close $8.69 → 2026-10-08 close $5.94
- P/En/a negative earnings
- Net margin-6.5% FY2025, SEC XBRL
- Gross margin+44.2% FY2025, SEC XBRL
- ROE-11.8% FY2025, SEC XBRL
- Debt / equity0.00 as of 2026-09-02
- Revenue growth (YoY)+3.4% as of 2026-09-02
- Revenue CAGR (3y)-2.6% SEC XBRL
- Beta0.92 as of 2026-09-02
- Last reported earnings2026-08-06 SEC EDGAR Form 8-K (Item 2.02)
How INGN compares in its sector
- net profit marginmiddle range 430 covered Health Care peers, as of 2026-09-02
- operating marginmiddle range 417 covered Health Care peers, as of 2026-09-02
- gross marginbottom 25% 189 covered Health Care peers, as of 2026-09-02
- return on equitymiddle range 510 covered Health Care peers, as of 2026-09-02
- 3-year revenue CAGRbottom 25% 402 covered Health Care peers
- free cash flow (absolute dollars, latest fiscal year)middle range 494 covered Health Care peers, as of FY2025
Position among covered Health Care companies that report each metric (minimum 5 peers). A relative position within our covered catalog — not a valuation, quality, or investment judgment. A higher percentile is simply a higher value (for P/E, more expensive on earnings — never "better"). Informational only.
How INOGEN INC looks technically
INOGEN INC (INGN) is trading 4.7% below its 200-day average, the long-term trend line — a long-term downtrend. Its 50-day average crossed below its 200-day average about 191 trading days ago — a "death cross", a bearish long-term signal. A strong uptrend is in place — ADX, a 0–100 trend-strength gauge, is 38, with buyers in control. Momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 62, neither overbought (above 70) nor oversold (below 30). It made a new 20-day high about 6 trading days ago. It is 34.9% below its highest point of the past year.
Trend
8
| Distance from the 200-day | it is trading 4.7% below its 200-day average, the long-term trend line — a long-term downtrend | -4.7% |
|---|---|---|
| 50-day moving average | its average price over the last 50 trading days — a short-term trend line — is $5.64 | $5.64 |
| 200-day moving average | its average price over the last 200 trading days — the long-term trend line — is $6.23 | $6.23 |
| Swing structure | each recent peak has been lower than the one before it and each dip deeper — the pattern chart-watchers call a downtrend, which describes where price has already been and not where it goes next | lower highs and lower lows |
| Last swing turn | its last significant turn was a swing high 7 calendar days ago — the swings before that are what the structure reading is measured on | 7 sessions |
| Wave structure | its recent swings can be read as a five-part downward sequence — what Elliott-wave chartists call an impulse — now in leg 3 of five; the labelling fails if price closes above 6.155. It is one of several labellings that fit, and it describes the swings already printed, not what comes next. The same swings also read as a three-part correction in leg C. | possible downward five-wave sequence, in wave 3 (one of several readings) |
| Since the 50/200 cross | its 50-day average crossed below its 200-day average about 191 trading days ago — a "death cross", a bearish long-term signal | 191 sessions |
| Trend strength (14-day ADX) | a strong uptrend is in place — ADX, a 0–100 trend-strength gauge, is 38, with buyers in control | 38.0 |
Momentum
3
| 14-day RSI | momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 62, neither overbought (above 70) nor oversold (below 30) | 62.4 |
|---|---|---|
| Position in its 14-day range | it is trading near the top of its 14-day range ($5.04 to $6.16) — its "stochastic" reading is 81 out of 100, where 0 would mean closing exactly at the 14-session low and 100 exactly at the high. This measures WHERE the price sits inside its recent range, which is a different question from the RSI beside it: RSI is a momentum gauge, measuring how FAST the price has been moving, so a stock can drift quietly to the bottom of its range with an ordinary RSI, or fall sharply and still sit in the middle. It has been climbing within that range over the last few sessions. | 80.6 |
| Since the MACD crossed zero | MACD, a trend-momentum gauge, is in positive territory (momentum leaning bullish) | 20 sessions |
Range
12
| 52-week high | its highest closing price over the past year (about 252 trading days) was $9.13 | $9.13 |
|---|---|---|
| From the 52-week high | it is 34.9% below its 52-week high (its highest price of the past year) | -34.9% |
| Above the 52-week low | it is 17.7% above its 52-week low (its lowest price of the past year) | +17.7% |
| Below the 52-week high | it is 34.9% below its highest point of the past year | 34.9% |
| Since a 20-day breakout | it made a new 20-day high about 6 trading days ago | 6 sessions |
| Since a 55-day breakout | it made a new 55-day low about 12 trading days ago | 12 sessions |
| All-time high | its highest closing price on record is $287.79 (set on 2018-09-13) | $287.79 |
| Given back of the 52-week move | over the past year its closes ranged ($5.09 to $8.95), and it has recovered roughly a quarter of its fall from last year’s high — 22% of it. Chart-watchers call 61.8%-65% given back the "golden pocket" — for this company that is $7.48 to $7.60. It is watched widely enough that orders cluster there, which is the honest reason it matters; it is not a forecast. | 22.0% |
| From the all-time high | it is 97.9% below its all-time high | -97.9% |
| Nearest price level | it is trading 1.0% below a resistance level at $6.00 — a price it turned at twice since 2026-01-12, most recently on 2026-03-13. Since 2024-10-08 it has 2 such levels below the current price and 14 above. Levels like these describe where the price has reversed or paused before; they are not a forecast of where it will go. | +1.0% |
| All-time low | its lowest closing price on record is $4.13 (set on 2023-10-27) | $4.13 |
| Above the all-time low | it is 43.8% above its all-time low | +43.8% |
Volatility
5
| Band width vs its own 6 months | day-to-day price swings are unusually wide versus its own recent history (wider than about 92% of the past ~6 months) | 92nd percentile |
|---|---|---|
| Typical daily range | in a typical session it travels about $0.2207 between its high and its low — about 3.7% of its price. That is its "average true range" over the last 14 sessions, which also counts the distance from the previous close, so a day that opens well away from yesterday counts as the large move it was | $0.2207 |
| Bollinger bands (20-day, ±2σ) | most of its recent trading has stayed between about $4.79 and $6.08 — the "Bollinger bands", a range drawn two standard deviations either side of its 20-day average price, which widens when the stock gets more volatile and narrows when it settles | $4.79 – $5.43 – $6.08 |
| Typical daily range (% of price) | its price moves about 3.7% in a typical session — about typical for the companies we cover. This is the average gap between a session's high and low over the last 14 sessions, counting overnight moves, expressed against the current price so it can be compared with companies trading at any price | 3.7% |
| Stretch from the 200-day average | it is trading 1.3 daily ranges below its 200-day average price (4.7% below it in plain percentage terms) — a way of asking how far it has stretched from its own average in units of how far it normally moves in a day, so a calm company and a jumpy one can be compared on the same scale | 1.3 daily ranges below its 200-day average |
Volume
1
| Volume vs its 30-day average | trading volume is about normal versus its 30-day average | 1.29× |
|---|
Analyst
2
| Change in the average price target | analysts' average price target is unchanged from the prior reading | 0.0% |
|---|---|---|
| Change in the consensus rating | not available for this company yet | n/a |
Candlestick patterns
1
| Since a doji | 3 sessions ago it opened and closed at almost the same price after trading through a wider range — a "doji", the classic picture of buyers and sellers finishing the session level | 3 sessions ago |
|---|
Price gaps
3
| Gap at the open | it opened on 2026-10-08 0.5% below the previous session's close — an overnight gap, the part of the move that happened while the market was shut, and traded back through that level before the close | -0.5% |
|---|---|---|
| Open gap | it gapped 5.1% above the previous close 5 sessions ago and has not traded back through the level it left behind at 5.27 — an "unfilled gap", which describes a price range no trade has since crossed and is not a forecast that it will be crossed | +5.1% |
| Gap filled | a 4.3% gap up opened on 2026-08-11 has been "filled" 41 sessions ago — price traded back through the level the gap left behind, and it closed again during the very session that opened it | 41 sessions ago |
Price streaks
1
| Closing streak | it has closed higher 2 sessions in a row, a +2.95% move over the run — an unbroken run of up days, which describes what has already happened and says nothing about the next session | 2 sessions up |
|---|
Relative strength
4
| vs market, 1 month | over the past 1 month this stock beat the market by 12.5 percentage points (the stock gained 13.6% while the market gained 1.0%) | +12.5% |
|---|---|---|
| vs market, 3 months | over the past 3 months this stock lagged the market by 12.3 percentage points (the stock lost 8.5% while the market gained 3.8%) | -12.3% |
| vs market, 6 months | over the past 6 months this stock lagged the market by 24.1 percentage points (the stock lost 6.6% while the market gained 17.5%) | -24.1% |
| vs market, 12 months | over the past 12 months this stock lagged the market by 46.6 percentage points (the stock lost 31.6% while the market gained 15.0%) | -46.6% |
Signal agreement
2
| Bullish technical signals | 2 of the 9 technical signals we can compute for it are currently in a bullish state: MACD momentum is positive, a strong uptrend, with buyers in control — these describe past price behaviour, not a forecast | 2 of 9 |
|---|---|---|
| Bearish technical signals | 4 of the 9 technical signals we can compute for it are currently in a bearish state: a "death cross" — its 50-day average is below its 200-day, trading below its 200-day average, lagging the market over 6 months, near the top of its 14-day range (overbought) — these describe past price behaviour, not a forecast | 4 of 9 |
Trend (Ichimoku cloud)
1
| Vs the Ichimoku cloud | trading inside the Ichimoku cloud — a band drawn from where its own highs and lows sat up to 2026-09-01 and projected forward over today's price, the zone traders read as unresolved — neither side has established a trend, and the band is where that gets settled. The band itself is moderate, spanning 6.4% of the share price. | 0.0% |
|---|
Volume-weighted price
2
| Vs this year’s average price paid | the price is 4% below the average price paid so far this year, so the typical buyer over that stretch is under water. That average is $6.19 — a volume-weighted average of daily closes over 190 sessions, not a true tick-by-tick VWAP. | -4.0% |
|---|---|---|
| Vs the average paid since it last reported | the price is 7% above the average price paid since it last reported on 2026-08-06 (its 8-K), so the typical buyer over that stretch is showing a gain. That average is $5.54 — a volume-weighted average of daily closes over 45 sessions, not a true tick-by-tick VWAP. | +7.2% |
Price levels it has turned at before
INGN last closed at $5.94 on 2026-10-08. Since 2024-10-08 it has turned at 2 prices below its last close and 14 above; the 2 nearest below and the 3 nearest above are listed, nearest first.
| Level | Side | Distance | Evidence |
|---|---|---|---|
| $6.00 | Resistance | 1.0% above the last close | turned there twice · 2026-01-12 to 2026-03-13 |
| $5.86 | Support | 1.4% below the last close | turned there three times · 2025-08-07 to 2026-06-03 |
| $6.20 | Resistance | 4.3% above the last close | turned there 8 times · 2025-06-03 to 2026-10-01 |
| $5.51 | Support | 7.2% below the last close | turned there twice · 2026-02-09 to 2026-09-08 |
| $6.59 | Resistance | 11.0% above the last close | turned there 8 times · 2025-03-31 to 2026-06-11 |
A level is a price this company reversed or paused at more than once — they describe past behaviour, not a forecast of where the price will go.
Wave structure
Its recent swings can be read as a five-part downward sequence — what Elliott-wave chartists call an impulse — now in leg 3 of five.
This labelling fails — stops being a possible reading at all — if it closes above $6.16.
This is one of several labellings that fit the same swings, so treat it as a reading rather than the reading. It was chosen from 2 labellings that survived the rules, counting shorter readings of the same bars.
On past moves of this shape the leg has usually ended somewhere between $2.86 and $4.12 — that is where it has tended to end if the count holds, not a forecast of where the price goes.
Alternate reading: The same swings also read as a three-part correction in leg C, which fails on a close above $6.16.
This reading has stood for 1 trading day, since 2026-10-08.
Read from daily closes as of 2026-10-08.
An Elliott-wave count describes the swings already printed and the level that would disprove it. It is not a forecast, a target, or advice.
Screens: Trading below the 200-day moving average · Pulled back from the 12-month high · in a strong, established uptrend (ADX) · lagging the market · At the top of its 14-day range (stochastic above 80) · Trading inside the Ichimoku cloud | Learn: moving average · golden cross · adx · rsi · breakout · fifty two week high low
Based on daily closing prices as of 2026-10-08. Describes past price behavior only — informational, not financial advice.
Analyst consensus
- Consensus ratingStrong Buy (1.50 mean, 1=Strong Buy…5=Strong Sell) — 2 analysts
- Mean price target$12.00 range $12.00 – $12.00
Analyst estimates, as of 2026-10-09. These are third-party analyst opinions and price targets, aggregated — not a recommendation, prediction, or advice from stocks-llm. Informational only.
Analyst EPS estimate for INGN
- Consensus EPS estimate-$0.06 next reporting period, as of 2026-10-09
- Estimate change, 30 days$0.00 from -$0.06, on 2026-09-04, 35-day window
- Readings revised upward0% of 8 comparable readings
The consensus estimate for the next reporting period, and how it has moved between readings of that SAME period. A change is measured only between readings estimating one period — when a company reports, the consensus moves to the next quarter and the two numbers are not comparable. Informational only, not a forecast and not advice.
Key risks (from latest filing)
["Dependence on home medical equipment providers for product distribution, who may be disincentivized from adopting POCs due to reimbursement structures.","Significant regulatory and reimbursement risks, including capped insurance reimbursement structures that limit patient adoption.","Challenges in achieving and maintaining consistent profitability."]
Insider activity (SEC Form 4)
No open-market insider purchases or sales recorded in the last 90 days, of which we have read Form 4 filings through 2026-10-04. The 5 days since 2026-10-04 have not been checked yet.
- Last 180 days · read to 2026-10-040 buys · 2 sells ($142459) — 1 selling insider
Most recent open-market transaction: 2026-07-01. Based on Form 4 filings read through 2026-10-04; anything filed since is not yet included.
View full insider trading history → View SEC Form 3/4/5 filingsAsk about INGN's insider activity →
Only open-market purchases (SEC code P) and sales (code S) are counted here. Option exercises, vesting/awards, gifts, and shares withheld for taxes are excluded — they are compensation or mechanical, not open-market conviction. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan) and are not necessarily bearish; open-market buying is not a recommendation to buy. Informational only — not financial advice.
Institutional ownership (13F)
4 institutional 13F filers reported holding INGN as of 2026-06-30 (quarter-end position, filed within 45 days).
- Distinct 13F filers 4
- Reported shares held 2,835,012
- Reported value $18,285,827
reported quarterly holdings change (2026-03-31 → 2026-06-30): 0 new, 3 increased, 1 decreased, 1 exited. Change counts cover only managers that filed 13F reports in BOTH quarters, derived between two quarter-end snapshots — not same-day trades; a single manager is never said to have "bought" or "sold".
Institutional holdings are quarter-end long positions reported on SEC Form 13F-HR, filed up to 45 days after the quarter ends — they are delayed, are not real-time trades, exclude short positions and most non-US securities, and are not investment advice. Any increase/decrease is a reported change between two quarterly snapshots, not a same-day purchase or sale. These are quarter-end snapshots from the 13F filings on SEC EDGAR, filed within 45 days — not real-time, and any change is a difference between two quarterly reports, not a same-day trade. Informational only — not financial advice.
Ask about INGN's institutional holders → See what each manager we track holds →
Short interest (FINRA)
INGN had 1,366,129 shares of reported short interest as of the 2026-09-15 FINRA settlement date (delayed, bi-monthly; not real-time).
INGN had 5.15% of its shares outstanding sold short as of the 2026-09-15 FINRA settlement date (percent of FLOAT would be higher — float is not disclosed in the source). FINRA reported 5.14 days to cover at the same settlement.
- Reported short interest (shares) 1,366,129
- Short interest (% of shares outstanding) 5.15%
- Prior settlement (shares) 1,462,458
- Reported change -6.59%
- Days to cover (reported) 5.14
Reported to FINRA as of the 2026-09-15 settlement date. Short interest is reported to FINRA and published on a delayed, bi-monthly schedule (as of a settlement date, disseminated roughly eight business days later) — it is NOT real-time, does not cover every venue or all US trading, and is not a short-squeeze prediction or investment advice. Days-to-cover is the value FINRA reports; percent of float is not shown because the source file carries no share-count denominator — where a percent appears it is of shares OUTSTANDING, the larger base, and is therefore a floor on percent of float. Informational only — not financial advice.
Competitors & peers
- ResMed (RMD)
- Philips Respironics (PHG)
- Fisher & Paykel Healthcare (FPHYY)
- Linde (LIN)
- Air Liquide (AIQUY)
- Drive DeVilbiss Healthcare
AI-enriched competitor set. Linked names are companies covered by stocks-llm; other named peers are shown for reference only.
Compare INGN vs…
Frequently asked questions
What does INOGEN INC (INGN) do?
Inogen is a medical technology company that develops, manufactures, and markets respiratory health products primarily for the homecare setting. Its core offerings include portable and stationary oxygen concentrators for chronic respiratory conditions like COPD, as well as airway clearance devices and CPAP masks. The company distributes its products globally, including through a strategic collaboration with Yuwell to enhance its presence in the Chinese market.
What sector is INOGEN INC (INGN) in?
INOGEN INC (INGN) is classified in the Health Care sector. Its industry is respiratory medical devices. It trades on NASDAQ.
Who are INOGEN INC's (INGN) competitors?
Notable peers of INOGEN INC (INGN) include ResMed, Philips Respironics, Fisher & Paykel Healthcare, Linde and Air Liquide. This peer set is informational only — not financial advice.
Is INOGEN INC (INGN) overbought or oversold right now?
INOGEN INC (INGN) is currently neither overbought nor oversold — its 14-day RSI (a 0–100 momentum gauge) is 62, in the neutral middle (as of 2026-10-08). RSI describes recent price momentum, not a forecast — informational only, not financial advice.
Where does stocks-llm's data on INGN come from?
Fundamentals come from SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-02 for the rest; prices are market data, as of 2026-09-02; company filings and profile facts come from SEC EDGAR. All figures are delayed daily-close data shown with their as-of date — informational only, not financial advice.
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-02 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-08.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date.